13th World ADC London 2023 ExCeL London, London
The 13th World ADC London returns in 2023 as Europe’s longest standing and definitive antibody-drug conjugate event – and it’s back bigger and better than before!
With the recent approvals of ImmunoGen’s ELAHERE, Astrazeneca and Daiichi Sankyo’s DESTINY-Breast04, supporting Enhertu’s use in HER2-low breast cancer as a new therapeutically targetable category, the ADC space has continued to make major waves throughout 2022, a joy to see for oncology patients around the world.
With high hopes set on Byondis for the next approval, you simply can’t miss out on this highly anticipated event. Exploring all aspects of ADC development from discovery to late-stage manufacturing, this is your one-stop shop for antibody-drug conjugate content.
No ADC stone is left unturned as we unite all leading players in the field under one roof. Wherever your interest and expertise lies, we have it covered at the industry’s leading conference to help forward-thinking researchers from the pharmaceutical, biotech, and academic community advance the development of antibody-drug conjugates.
⌛ Event Dates & Venue
💸 Website & Tickets
Go to Event WebsiteWorldADC
Industry Pricing: Conference + Seminar Day + Workshop Day (Full 4 Day Access Pass): GBP 4595.00, Industry Pricing: Conference + Seminar day OR Workshop Day (3 Day Pass): GBP 3597.00, Industry Pricing: Conference only (2 Day Pass): GBP 2599.00, Academic Pricing: Conference + Seminar Day + Workshop Day (Full 4 Day Access Pass): GBP 3695.00, Academic Pricing: Conference + Seminar day OR Workshop Day (3 Day Pass): GBP 2897.00, Academic Pricing - Conference only (2 Day Pass): GBP 2099.00, Solution Provider Pricing: Conference + Seminar Day + Workshop Day (Full 4 Day Access Pass): GBP 5195.00, Solution Provider Pricing: Conference + Seminar day OR Workshop Day (3 Day Pass): GBP 4197.00, Solution Provider Pricing: Conference only (2 Day Pass): GBP 3199.00
Advertisements